Europlasma SA (ALEUP) Stock Statistics & Valuation Metrics

Europlasma SA has a market cap or net worth of €1.70M. The enterprise value is €6.83M.

Europlasma SA has 1,697,110,500 shares outstanding. The number of shares has decreased by -2.65% in one year.

Europlasma SA’s return on equity (ROE) is 1.68 and return on invested capital (ROIC) is -251.10%.

The current PE Ratio of Europlasma SA is ―. Europlasma SA’s PEG ratio is >-0.00001.

In the last 12 months, Europlasma SA had revenue of 70.42M and earned -35.59M in profits. Earnings per share was -6.67.

In the last 12 months, operating cash flow was -14.89M and capital expenditures -5.46M, giving a free cash flow of -20.35M billion.

Europlasma SA pays an annual dividend of ―, resulting in a dividend yield of ―

Europlasma SA upcoming earnings date is Oct 29, 2024, TBA (Confirmed).

Europlasma SA as a current ratio of 0.66, with Debt / Equity ratio of -93.84%

In the past 12 months, Europlasma SA has paid -678.00K in taxes.

Europlasma SA EV to EBITDA ratio is -0.66, with an EV/FCF ratio of -0.67.

Europlasma SA has €7.46M in cash and marketable securities with €19.93M in debt, giving a net cash position of -€12.47M billion.

Gross margin is 42.89%, with operating margin of -41.42%, and net profit margin of -50.54%.

The average price target for Europlasma SA is ―, which is 11.43% higher than the current price. The consensus rating is ―